Prospective Observational Study to Monitor and Assess the Safety of Amvuttra® [Vutrisiran] in a Real-World Cohort of hATTR Amyloidosis PatientsFirst published 22/01/2024 Last updated 07/05/2025 EU PAS number: EUPAS108904StudyOngoing
United BioSource Corporation (UBC)Switzerland First published: 25/04/2013Last updated 06/03/2024 InstitutionNon-Pharmaceutical companyENCePP partner